US Pre-Market SEC Filings Roundup — October 23, 2026

22-10-2026

Director Gomez Aidan N. had withheld for taxes 420 Class A Common Stock at $12.34 (~$5.18K). Gomez Aidan N. holds 63,564 shares after the transaction.

• · Director Gomez Aidan N. was awarded 807 Class A Common Stock
• · Director Gomez Aidan N. had withheld for taxes 420 Class A Common Stock at $12.34 (~$5.18K)

22-10-2026

Chief Executive Officer Zhao Bin bought 9,971 ADS at $4.39 (~$43.7K). 4 transactions reported in total. Zhao Bin holds 2,204,735 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Chief Executive Officer Zhao Bin bought 9,971 ADS at $4.39 (~$43.7K)
• · Chief Executive Officer Zhao Bin bought 9,794 ADS at $4.36 (~$42.7K)
• · Chief Executive Officer Zhao Bin bought 9,513 ADS at $4.46 (~$42.4K)
• · Chief Executive Officer Zhao Bin bought 8,989 ADS at $4.40 (~$39.5K)

22-10-2026

Chief Operating Officer Jewett Sarah Allison exercised/converted 59,125 Class A Common Stock at $1.31 (~$77.5K). Jewett Sarah Allison holds 416,808 shares after the transaction.

• · Chief Operating Officer Jewett Sarah Allison exercised/converted 59,125 Class A Common Stock at $1.31 (~$77.5K)
• · Chief Operating Officer Jewett Sarah Allison exercised/converted 59,125 Stock Option

22-10-2026

Director Alford Tony L bought 268,663 Warrants.

• · Director Alford Tony L bought 268,663 Warrants

22-10-2026

Director WHITMAN MARGARET C was awarded 122 Class A Common Stock. WHITMAN MARGARET C holds 7,922 shares after the transaction.

• · Director WHITMAN MARGARET C was awarded 122 Class A Common Stock

22-10-2026

Director Whiteside Janey was awarded 775 Class A Common Stock. Whiteside Janey holds 61,479 shares after the transaction.

• · Director Whiteside Janey was awarded 775 Class A Common Stock

22-10-2026

Chief Executive Officer Shrestha Sanjay K was awarded 2,000,000 Class A Common Stock. 4 transactions reported in total. Shrestha Sanjay K holds 500,000 shares after the transaction.

• · Chief Executive Officer Shrestha Sanjay K was awarded 2,000,000 Class A Common Stock
• · Chief Executive Officer Shrestha Sanjay K was awarded 1,500,000 Class A Common Stock
• · Chief Executive Officer Shrestha Sanjay K was awarded 1,500,000 Class A Common Stock
• · Chief Executive Officer Shrestha Sanjay K was awarded 500,000 Class B Common Stock

22-10-2026

Director Kneppers Chris J sold 125,510 Common Stock at $0.10 (~$12.6K). Kneppers Chris J holds 19,747,167 shares after the transaction.

• · Director Kneppers Chris J sold 125,510 Common Stock at $0.10 (~$12.6K)

23-10-2026

Zymeworks (Nasdaq: ZYME) entered into an exclusive global license and collaboration agreement with Roche for ZW209, a DLL3-targeting trispecific T cell engager, under which Zymeworks receives a $55 million upfront payment and a $40 million payment upon initiation of the Phase 1b trial, plus up to $718 million in development, commercial and sales-based milestones and tiered high-single-digit to mid-teen royalties on net sales. Roche will fund the Phase 1a monotherapy trial and take over global development and commercialization; the deal is subject to HSR waiting-period expiry and other customary closing conditions. The filing does not disclose any negative or flat financial metrics, so the tone is positive, though the economics are contingent on milestones, approvals and closing.

• · ZW209 has U.S. FDA IND clearance; additional global regulatory applications are planned to open clinical sites outside the U.S.
• · ZW209 targets DLL3 and engages CD3 and CD28, with conditional CD28 co-stimulation intended to prevent unintended T cell activation
• · Target indications include small cell lung cancer and other DLL3-expressing neuroendocrine tumors
• · Zymeworks is also eligible for milestone and royalty economics in its licensed-asset portfolio; a conference call is scheduled for October 27, 2026 at 8:30 am ET

23-10-2026

Zai Lab furnished an October 2026 corporate presentation (Exhibit 99.1) highlighting ESMO 2026 data for its DLL3-targeted ADC zocilurtatug pelitecan (zoci, ZL-1310) in small cell lung cancer (SCLC) and neuroendocrine carcinoma (NEC). In 1L ES-SCLC, zoci 1.6 mg/kg plus atezolizumab showed an 81.8% ORR (27 of 33 patients, all partial responses, no complete responses) with a preliminary median DoR not reached and a 6-month PFS rate of 81.9% at a median follow-up of 4.6 months; however, 2 patients (6.1%) had progressive disease, 2 had stable disease, and the data are early, with 25 of 33 patients still on treatment and safety data described as preliminary. Grade ≥3 treatment-related AEs were 9.1% in the 1.6 mg/kg doublet arm, while the triplet with carboplatin was not selected as the go-forward combination.

• · Zoci 1.2 mg/kg + atezolizumab: 80% ORR (8 of 10 PR, 2 SD), with 50% Grade ≥3 AEs overall in that arm
• · Triplet cohorts (zoci + atezolizumab + carboplatin, n=13) were not selected as the go-forward combination; the doublet was chosen
• · Among 1L SCLC, 0 complete responses were observed in the doublet cohorts
• · Grade ≥3 AEs overall in 1.6 mg/kg doublet arm were 21.2% (7 of 33), with 9.1% related to zoci
• · Drug interruptions occurred in 27.3% of 1.6 mg/kg doublet patients; 1 discontinuation in the 1.2 mg/kg arm
• · Company describes safety data as preliminary due to ongoing dose expansion and data cleaning
• · Trial data cutoff was September 9, 2026; minimum 12-week follow-up required for inclusion

23-10-2026

S&P Global Inc. filed a Form 8-K furnishing unaudited pro forma condensed consolidated financial statements (income statements for the six months ended June 30, 2026 and fiscal years 2023–2025, plus a June 30, 2026 balance sheet) to reflect the July 1, 2026 separation of its S&P Global Mobility segment into the independent public company Mobility Global Inc. The filing itself contains no specific revenue, earnings, or margin figures; the financial data resides in Exhibit 99, which was not included in the provided content.

• · Separation completed July 1, 2026; Mobility Global Inc. is now an independent public company
• · Pro forma statements cover the six months ended June 30, 2026 and fiscal years 2023, 2024 and 2025
• · Financial details are contained in Exhibit 99 and XBRL cover page in Exhibit 104

23-10-2026

STARRY SEA ACQUISITION CORP (SSEAR) filed Amendment No. 1 on Form 8-K/A to correct the number of ordinary shares tendered for redemption reported in its October 21, 2026 Original 8-K. In connection with the shareholders' vote at the Extension Meeting held October 19, 2026, 3,896,270 ordinary shares were tendered for redemption, and the Monthly Extension Fee was set at $60,000 per one-month extension.

• · The filing is an amendment solely to correct the redemption share count reported in the Original 8-K filed October 21, 2026; all other Original 8-K disclosures are unchanged
• · Registrant is a Cayman Islands special purpose acquisition company (SPAC) and an emerging growth company, with principal offices in Albany, NY

23-10-2026

Limitless X Holdings Inc. filed a Certificate of Amendment (Exhibit 3.1) reducing the number of shares designated as Class B Convertible Preferred Stock from 11,000,000 to 1,500,000, a decrease of 9,500,000 shares that return to authorized but unissued preferred stock. The Board approved the amendment by unanimous written consent dated October 13, 2026, and the certificate was executed by CEO Jaspreet Mathur on October 19, 2026. The amendment is effective upon filing and, per the Board, does not alter rights of the 1,081,356 outstanding Class B shares, which remain above the new cap.

• · Board approved the amendment by unanimous written consent dated October 13, 2026, under Article IV of the A&R Certificate and Section 151(g) of the DGCL.
• · The Board determined no Class B holder consent was required because the decrease affects only authorized but unissued shares and is not adverse to Class B holders.
• · Outstanding Class B shares (1,081,356) remain below the new 1,500,000 designation, leaving roughly 418,644 undesignated-but-unissued Class B headroom.
• · The Class B Certificate of Designation was originally filed October 23, 2023.

23-10-2026

Flagstar Bank, N.A. (NYSE: FLG) reported Q3 2026 net income of $12 million (vs. $34 million in Q2 2026 and a $36 million net loss in Q3 2025), resulting in net income attributable to common stockholders of $3 million, or $0.01 per diluted share. Net interest income rose 5% QoQ to $460 million and net interest margin expanded 4 basis points to 2.17%, while total loans grew 2% QoQ to $61.9 billion driven by a 11% increase in C&I loans to $20.6 billion. However, the provision for credit losses rose $58 million QoQ to $76 million, non-interest income fell 26% YoY, and management pushed the full realization of its long-term strategic objectives from 2027 to 2028 due to a higher-for-longer rate environment.

• · Net income attributable to common stockholders fell to $0.01 per diluted share from $0.06 in Q2 2026, a decline of roughly 83%
• · Provision for credit losses increased $58 million QoQ to $76 million, primarily from higher interest rates including on the NYC rent-regulated multi-family portfolio
• · Non-interest income declined 26% YoY to $70 million, with mortgage banking gain-on-sale income, BOLI, and other income all down
• · Non-interest-bearing checking deposits grew 6% QoQ, while interest-bearing and money market deposits fell 6% QoQ
• · Substandard loans rose $248 million (4%) QoQ and total Criticized/Classified loans rose $670 million (6%) QoQ
• · NYC multi-family loans declined $531 million (4%) QoQ, and the multi-family ACL coverage stands at 1.63%
• · Average borrowings declined 21% YoY to $10.5 billion as the Bank continued paying down wholesale borrowings
• · Income tax benefit of $22 million in Q3 2026 versus $14 million expense in Q2 2026
• · Deposit cost increased 1 basis point QoQ while overall cost of funds rose 2 basis points
• · Total cash and cash equivalents fell 21% QoQ to $4.0 billion

23-10-2026

UY Scuti Acquisition Corp. (UYSCU) filed a Rule 425 communication (Form 8-K) disclosing the September 22, 2026 joinder and First Amendment to its July 18, 2025 merger agreement with Isdera Group Limited, which will become the parent of Xinghui Automotive Technology (Hainan) Co., Ltd. The company also issued two unsecured, non-interest-bearing promissory notes on October 22, 2026: a $900,000 note to Isdera HK Limited covering two $450,000 trust extension loans, and a note of up to $200,000 to Xinghui Automotive Technology, of which $135,154 was outstanding at issuance. Both notes are due at business combination closing and are convertible into units at $10.00 unless the holder becomes a subsidiary of the Purchaser, in which case they are settled at closing.

• · Third three-month extension period runs to January 1, 2027, following the earlier extension to October 1, 2026
• · Notes are unsecured, bear no interest, and mature on business combination closing
• · Conversion right terminates if the holder becomes a Purchaser subsidiary at closing; balances are then cash-repaid, set off, or settled intercompany
• · Notes were issued under the Section 4(a)(2) private placement exemption
• · Merger Agreement was entered July 18, 2025; Purchaser and Merger Sub formed August 2025

23-10-2026

Alterity Therapeutics Limited filed a Form 6-K for October 2026 that incorporates by reference its existing Form S-8 and Form F-3 registration statements and submits Exhibit 99.1, a 'Proposed issue of securities - ATH'. The filing text itself contains no amounts, share counts, pricing, or financial results, so the economic terms of the proposed securities issue cannot be determined from this document alone.

• · Exhibit 99.1 is titled 'Proposed issue of securities - ATH', indicating a proposed securities issuance, though the exhibit terms are not reproduced in the provided text
• · Filing is a Form 6-K for the month of October 2026, submitted by a foreign private issuer that files annual reports on Form 20-F
• · Filing is incorporated by reference into Form S-8 registration statements (333-251073, 333-248980, 333-228671) and Form F-3 registration statement (333-274816)
• · Registrant address is Level 15, 500 Collins Street, Melbourne, Victoria 3000, Australia

23-10-2026

Melco Resorts & Entertainment Limited (MLCO) filed a Form 6-K for October 2026 that primarily serves as a transmittal document. It attaches Exhibit 99.1, an announcement by its parent, Melco International Development Limited, regarding a discloseable transaction involving an investment in the Macao SAR Government Guidance Fund No.2, Limited Partnership Fund, dated October 23, 2026. The filing body itself contains no financial results, specific amounts, or quantitative performance data.

• · The 6-K is a Form 20-F filer report under Rule 13a-16, with the parent's Hong Kong-listed announcement appended as Exhibit 99.1
• · The safe harbor statement flags risks including Macau gaming market changes, the amended Macau gaming law implementation, and gaming authority approvals
• · The underlying transaction is classified by the parent as discloseable under Hong Kong listing rules, but the deal size is not disclosed in this filing

23-10-2026

Primis Financial Corp. (NASDAQ: FRST) reported Q3 2026 net income available to common shareholders of $8.7 million ($0.35 per diluted share), up from $6.8 million ($0.28) in Q3 2025, and declared a quarterly cash dividend of $0.10 per share. Nine-month 2026 net income fell to $25.4 million ($1.03 per diluted share) from $31.9 million ($1.29) in the prior-year period, which included a $32.0 million investment gain, while Q3 mortgage volume and retail mortgage pipeline faced significant headwinds, and the company did not reach its 1.00% ROAA target this quarter.

• · Q3 2026 Pre-Tax Pre-Provision Operating Net Income was $12.0M versus $8.7M in Q3 2025
• · Net interest margin expanded to 3.66% (3.59% adjusted for recovery) from 3.18% a year earlier
• · Core net charge-offs rose to 17 basis points, up 14 basis points year-over-year
• · Allowance for credit losses declined to 1.30% of loans HFI from 1.40% a year earlier
• · FHLB advances were $220M at Sept 30, 2026, down from $300M in Q2 2026 but up from $85M a year earlier
• · Primis Mortgage pre-tax result was a loss of approximately $0.3M in Q3 2026 versus $1.9M earnings in Q3 2025
• · Panacea customer deposits grew 56% year-over-year to $207M
• · Digital platform small business balances reached $54M, up from $16M at December 31, 2025
• · Company expects approximately $3.0M in annualized savings from vendor consolidation beginning early 2027
• · Company stated it would have reached its 1.00% ROAA target this quarter absent mortgage headwinds

23-10-2026

Amber International Holding Limited (AMBR), a Singapore-based foreign private issuer, filed a Form 6-K for October 2026 furnishing a press release as Exhibit 99.1. The filing itself is a cover document with signatures by Chairman and CEO Michael Wu; no financial figures, operating metrics, or substantive disclosures are contained in the excerpt provided.

• · Commission File Number 001-38313; principal executive office at 1 Wallich Street, #30-02 Guoco Tower, Singapore 078881
• · Registrant files annual reports on Form 20-F (not Form 40-F)
• · Substantive content is incorporated by reference to Exhibit 99.1 (press release), which is not included in the provided text

23-10-2026

Rave Restaurant Group, Inc. filed definitive additional proxy materials (DEFA14A) on October 23, 2026, supplementing its proxy solicitation for shareholder meeting matters. The filing is a cover-page submission with no fee required and no financial results, transaction terms, or quantitative disclosures contained in the excerpt provided. Substantive proxy content would reside in the attached or referenced materials not included here.

• · Filing made as Definitive Additional Materials under Schedule 14A, filed by the Registrant.
• · No filing fee required for this submission.
• · The excerpt contains only the cover page; the substantive proxy content is not included in the provided text.

23-10-2026

KT Corporation initiated international arbitration before the Permanent Court of Arbitration seeking a put option payment of approximately USD 152 million from the Government of Rwanda and related entities under a shareholders' agreement. The Counterclaimants responded with a counterclaim of approximately USD 386 million, alleging KT breached the same agreement, which KT plans to vigorously contest. The counterclaim equals about KRW 512.4 billion, or roughly 2.63% of KT's consolidated equity of KRW 19,458.0 billion as of December 31, 2025.

• · Counterclaim exposure of KRW 512.4 billion is about 2.63% of consolidated equity, a relatively modest share of KT's balance sheet
• · The counterclaim amount was computed by Counterclaimants using unilateral assumptions, which KT disputes
• · The counterclaim was submitted and confirmed on October 21, 2026, with the filing dated October 20, 2026
• · Counterclaim-to-claim ratio is roughly 2.5x in USD terms, indicating the dispute's net exposure skews against KT if the counterclaim prevails

23-10-2026

United Microelectronics Corporation (UMC) furnished a Form 6-K report of foreign issuer dated October 23, 2026, under Rule 13a-16 of the Securities Exchange Act of 1934. The filing is a cover-and-signature document that references Exhibit 99 ("6K on 10/23/2026") as the substantive content, but the exhibit's text is not included in the material provided, so no financial results, transactions, or other specific business developments can be identified from this filing alone.

• · Commission File Number 001-15128; principal executive office at No. 3 Li-Hsin 2nd Road, Hsinchu Science Park, Hsinchu, Taiwan, R.O.C.
• · Registrant is a foreign private issuer filing a 6-K rather than a 20-F or 40-F annual report
• · Exhibit 99 is referenced as the substantive attachment but its contents are not provided in the filing text analyzed

23-10-2026

GasLog Partners LP furnished a Form 6-K on October 23, 2026, attaching a press release (Exhibit 99.1) that reports results for the three-month period ended September 30, 2026. The filing body itself contains no financial figures; the quantitative results reside in the attached exhibit, which is not included in the provided content. Because the substantive financial data is not available in this filing text, no performance metrics can be verified.

• · Filing is a Form 6-K for the month of October 2026 under Commission File Number 001-36433
• · Registrant is a foreign private issuer; cover page indicates it files under Form 20-F
• · Press release (Exhibit 99.1) dated October 23, 2026 relates to results for the three-month period ended September 30, 2026
• · Principal executive office is c/o GasLog LNG Services Ltd., 69 Akti Miaouli, 18537 Piraeus, Greece

23-10-2026

Evaxion A/S (EVAX), a clinical-stage TechBio company developing AI-Immunology-powered vaccines, furnished a 6-K attaching a press release announcing 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in its Phase 2 trial of the personalized cancer vaccine EVX-01. The filing itself contains no financial results, monetary amounts, or period-over-period comparisons, so the announcement is clinical rather than financial in nature.

• · Filing made under Form 20-F registration status (foreign private issuer), Commission File Number 001-39950
• · Press release furnished as Exhibit 99.1 and incorporated by reference into multiple Form S-8, F-3, and F-1 registration statements

23-10-2026

Inflection Point Acquisition Corp. VI (a Cayman Islands SPAC) and Quantum Space, LLC filed Amendment No. 1 to Form S-4 on October 22, 2026 for a proposed business combination under a Business Combination Agreement signed June 8, 2026, as amended October 22, 2026. The transaction will domesticate the SPAC into Delaware, merge it with a PubCo subsidiary, and recapitalize Quantum Space into an Up-C structure, with PubCo renamed Quantum Space, Inc. The filing registers up to 106,680,270 Class A-1 common shares, 6,272,380 Series A preferred shares, 15,833,333 warrants, and 14,117,645 Series A preferred investor warrants; the filing excerpt does not disclose valuation, financial results, or redemption outcomes.

• · Redemption scenarios modeled at 0%, 50%, and 100% of maximum, with proceeds from trust account, PIPE closing proceeds, and deferred underwriting fee reductions varying by scenario (values not disclosed in the excerpt).
• · Inflection Point will deregister in the Cayman Islands and domesticate to Delaware as an intermediate step before the merger.
• · Quantum Space OpCo will become a subsidiary of Post-Domestication Inflection Point under an Up-C structure.
• · Filing is a preliminary, subject-to-completion proxy statement/prospectus; securities may not be issued until the registration statement is declared effective.
• · Filing registrants are classified as non-accelerated filer, smaller reporting company, and emerging growth company.

23-10-2026

Inflection Point Acquisition Corp. VI (IPFX), a Cayman Islands SPAC, filed a Rule 425 communication on Form 8-K disclosing an October 22, 2026 Amendment to its June 8, 2026 Business Combination Agreement with Quantum Space, LLC and related PubCo and Merger Sub entities. The amendment shifts the intended listing venue of the PubCo Class A-1 Common Stock and PubCo Warrants from Nasdaq to the New York Stock Exchange, replaces the fixed seven-director post-closing board with a number determined by Quantum Space (with Inflection Point approval, not to be unreasonably withheld), and replaces the capitalization table annex. The filing discloses no dollar amounts, valuation figures, or redemption results.

• · Amendment dated October 22, 2026 replaces Annex 3.03(a) (Capitalization Table) to the Company Disclosure Letter in its entirety
• · NYSE listing condition to Closing and the director independence requirement are conformed to refer to NYSE instead of Nasdaq
• · Registration Statement on Form S-4 has been filed with the SEC; definitive proxy statement/prospectus not yet effective or mailed
• · Inflection Point IPO final prospectus (File No. 333-292443) was filed March 30, 2026
• · Original Business Combination Agreement was filed as Exhibit 2.1 to the June 12, 2026 Form 8-K; the Amendment is filed as Exhibit 2.1 to this filing
• · Forward-looking risk factors cited include redemption levels by Inflection Point shareholders, failure to obtain shareholder approval or financing, and satellite launch and operational risks specific to Quantum Space

23-10-2026

Antalpha Platform Holding Company furnished a Form 6-K for October 2026 that incorporates by reference Exhibit 99.1, a press release dated October 22, 2026, into its Form F-3 registration statement. The filing body itself contains no quantitative financial results, guidance, or operational details, so its substantive content cannot be assessed from this document alone.

• · Exhibit 99.1 (press release dated October 22, 2026) is incorporated by reference into Form F-3 registration statement File No. 333-297222, indicating the content may be relevant to an existing shelf registration.
• · Registrant is a foreign private issuer headquartered at 7 Temasek Boulevard, Suntec Tower 1, Singapore; Commission File No. 001-42637.
• · The 6-K body and signature do not disclose any financial figures; the press release content must be reviewed to determine materiality.

23-10-2026

Apex Critical Metals Corp. furnished a Form 6-K under which Exhibit 99.1, a press release dated October 22, 2026, announces its Nasdaq listing and the pricing of a US$1.86 Million offering. The filing itself is a cover document with incorporation by reference into Form F-10 (File No. 333-298319) and contains no detailed financial statements or performance metrics. The offering size is the only quantitative figure disclosed in the body text, and the full terms are contained in the exhibit, which is not reproduced here.

• · Filing is a Form 40-F filer (Canadian multijurisdictional disclosure system) with principal executive office in Vancouver, British Columbia
• · Exhibit 99.1 is incorporated by reference into Form F-10 registration statement File No. 333-298319
• · Commission File Number 001-42949

23-10-2026

Lunai Bioworks Inc. (Nasdaq: LNAI) received a Nasdaq Listing Qualifications letter on October 21, 2026 stating it no longer complies with Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2.5 million, after reporting a stockholders' deficit of $(9,024,946) in its FY2026 Form 10-K (fiscal year ended June 30, 2026). Rather than contest the determination, the Board approved voluntary delisting on October 22, 2026, with trading expected to be suspended on October 30, 2026 and delisting effective around November 12, 2026. The company does not intend to arrange over-the-counter quotation, so a trading market may not exist after Nasdaq suspension.

• · Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), which led Nasdaq staff to determine delisting
• · Company will not request a hearing and will not pursue OTC quotation for its common stock
• · Form 25 expected to be filed on or about November 2, 2026; Form 15 to suspend SEC reporting to follow, to the extent eligible
• · SEC reporting obligations continue unless and until terminated or suspended under SEC rules

23-10-2026

Valliance Asset Management Ltd (CIK 0001846639, Hong Kong-based) filed a Form 13F-HR on October 23, 2026 for the reporting period ended September 30, 2026. The filing's information table lists no holdings: the reported aggregate value and position entries are zero, and the filing shows no positions with sole, shared, or other voting or investment authority. The filing is a routine quarterly institutional holdings disclosure with no reported equity exposure.

• · Form 13F-HR filed under SEC file number 028-21042 with reporting period ending September 30, 2026
• · Filer is based at 16/F, 8 Queen's Road, Central, Hong Kong
• · Filing contains a single information table reporting zero holdings and zero aggregate value
• · Filing indicates the manager is not reporting any 13(f) securities for the quarter; no other included managers are named

23-10-2026

GeoPark Ltd (GPRK) has launched a tender offer for any and all of its outstanding 8.750% Senior Notes due 2030, with dealer managers Citigroup Global Markets Inc., Deutsche Bank Securities Inc., and J.P. Morgan Securities LLC. Based on the tender results shown, holders validly tendered U.S.$266,832,000 of the U.S.$441,679,000 outstanding principal, leaving U.S.$174,847,000 outstanding after settlement, a reduction of roughly 60% in the notes' principal. The consideration per U.S.$1,000 principal amount is U.S.$1,027.50.

• · Consideration of U.S.$1,027.50 per U.S.$1,000 principal is a premium over par, a typical feature of tender offers designed to induce early tenders.
• · Filing identifies 144A (CUSIP 37255B AC3, ISIN US37255BAC37) and Reg S (CUSIP G38327 AD7, ISIN USG38327AD78) tranches of the notes.
• · Remaining outstanding notes of U.S.$174.847M continue to carry the 8.750% coupon through their 2030 maturity.

23-10-2026

Omnicom reported Q3 2026 revenue of $6,422.8M, up 59.1% YoY from $4,037.1M, and nine-month revenue of $19,228.2M, up 63.7% from $11,743.1M. Net income attributable to Omnicom rose 92.2% to $656.0M for the quarter and 85.6% to $1,646.0M for the nine months, though operating cash flow for the nine months was only $37.8M (versus negative $99.2M a year earlier) and cash fell 44.8% to $3,796.4M as the company spent heavily on share repurchases. Growth is largely acquisition-driven (depreciation and amortization rose sharply), and several metrics were mixed, including Advertising (+39.6% quarterly), Integrated Media (+58.4%), and Europe (+27.9%), while Asia-Pacific, Latin America, and Middle East and Africa grew at varying rates and Latin America and MEA remain small in absolute terms.

• · Nine-month share repurchases of $3,210.3M and a $3,315.2M treasury stock charge far exceeded operating cash flow of $37.8M, funded partly by $2,384.9M of new borrowings
• · Long-term debt rose to $9,389.5M from $7,655.0M at December 31, 2025, while total equity fell to $10,325.9M from $12,693.0M
• · Accounts payable declined to $18,148.8M from $20,659.5M and accounts receivable fell to $13,223.6M from $14,398.0M, consistent with the $2,315.4M use of operating capital
• · Depreciation and amortization nearly tripled to $499.8M for nine months (from $178.4M), with intangible amortization rising to $355.2M from $75.0M, reflecting acquisition activity
• · Net gain on assets held for sale and dispositions of $106.8M in Q3 2026 and $72.5M for nine months, with $413.9M of disposal proceeds
• · Q3 2026 severance and repositioning costs of $84.7M, up from $38.6M, and nine-month costs of $135.8M versus $127.4M
• · Cost of services rose to 78.8% of revenue in Q3 2026 versus 81.3% in Q3 2025, indicating margin improvement at the cost line
• · Basic EPS was $2.39 in Q3 2026 versus $1.76 a year earlier; diluted EPS was $2.38 versus $1.75
• · Dividends declared per share rose to $0.80 in Q3 2026 from $0.70, and to $2.40 for nine months from $2.10
• · Latin America and Middle East and Africa revenue remain small contributors ($238.2M and $160.0M in Q3) despite high percentage growth
• · Q3 2026 foreign currency translation adjustment was a $33.2M gain versus a $60.6M loss in Q3 2025, while nine-month FX translation swung to a $3.6M loss from a $155.2M gain

23-10-2026

Powerus Corporation (filing header and signature reference the registrant as Powerus Corporation, trading as PUSA on Nasdaq, while the user referenced Aureus Greenway Holdings Inc (AGH); the filing itself does not mention AGH) entered into an employment agreement on October 17, 2026 with Leah Lunger, a Certified Public Accountant, to serve as Chief Accounting Officer, with a start date of November 16, 2026. Her base salary is $235,000, plus target annual incentive eligibility, a grant of 150,000 non-qualified stock options and 50,000 restricted stock units vesting quarterly over four years, and three months of base salary as severance if terminated without cause. No departure or dissolution of existing officers is disclosed in this filing.

• · Ms. Lunger, age 36, previously served at Red Cat Holdings as CFO (2024-2025), VP of Finance (2023-2024) and Corporate Controller (2020-2023)
• · Prior to Red Cat, Ms. Lunger was Controller of Fat Shark Holdings (2017-2020), later acquired by Red Cat
• · Ms. Lunger has no family relationships with directors or executive officers and no Item 404(a) related-party interests
• · Employment agreement filed as Exhibit 10.1; Cover Page XBRL filed as Exhibit 104
• · Filing references Nasdaq-listed common stock, par value $0.001, under symbol PUSA; company is an emerging growth company

23-10-2026

Boxlight Corp filed Amendment No. 1 to its Form S-1 registering the resale of 47,466,613 shares of common stock by selling stockholders, against only 844,556 shares outstanding before the offering. The company will receive no proceeds from these resales, but it has raised $5.5 million from the first tranche of Series D Preferred Stock, with a further $2.0 million tranche tied to registration effectiveness and stockholder approvals, and may receive up to $15.0 million from Secure Net Capital LLC under an equity purchase agreement. The filing highlights substantial dilution risk from floating-price convertible obligations to J.J. Astor and Secure Net Capital, alongside Nasdaq continued-listing risk.

• · Shares offered for resale (47,466,613) are roughly 56 times the 844,556 shares outstanding before the offering, implying massive potential dilution.
• · J.J. Astor conversion pricing floats at 90% of the lowest 20-day VWAP, and unpaid Make Whole Payments accrue 19% interest compounded daily.
• · If stockholder approval is not obtained, J.J. Astor obligations may have to be paid in cash, adversely affecting liquidity.
• · ELOC puts are priced at 95% of the lowest daily VWAP (regular) or lowest intraday traded price (intraday puts).
• · Company has never paid cash dividends and intends to use funds for growth, term debt paydown, and Series A preferred dividend obligations.
• · Company is a smaller reporting company with reduced disclosure requirements; risks of Nasdaq delisting and penny stock classification are disclosed.

23-10-2026

Independence Asset Advisors, LLC (Wynnewood, PA) filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing 31 holdings with a total reported market value of approximately $425.2 million (425,194,843 in thousands-based reporting, presented here as reported). The portfolio is concentrated in ETFs and index funds, with the largest positions in the VanEck CLO ETF (about $100.8 million) and the Vanguard Total Stock Market index fund (about $133.3 million). Individual equity holdings are minimal, limited to Apple and Berkshire Hathaway Class B.

• · Equity exposure is almost entirely through ETFs and index funds; only two individual stocks (Apple and Berkshire Hathaway Class B) appear, each under $2.5 million.
• · Fixed income and CLO-related ETFs (VanEck CLO ETFs, J.P. Morgan Active Bond ETF, Vanguard High-Yield Active) constitute a meaningful share of the reported value.
• · The 13F covers a combination report with 7 other institutional managers named as co-filers (e.g., Aristotle Capital, Fiera Capital, Loomis Sayles, Martingale, Security Capital Research & Management).

23-10-2026

K&F Growth Acquisition Corp. II (KFIIU), a SPAC, filed a Rule 425 communication sharing a CEO email and LinkedIn post from David's Bridal, Inc. about a previously disclosed, amended letter of intent for a potential business combination with Pearl, David's Bridal's wedding planning, media and commerce division. The filing is primarily a required legal disclosure package (forward-looking statements, proxy solicitation and participant notices) and states that no definitive agreement has been signed. It also notes the Company's October 16, 2026 extension proxy seeking shareholder approval to extend its business combination deadline.

• · The letter of intent with Pearl has been amended and no definitive business combination agreement is referenced as signed.
• · The Company will need to file a Form S-4 registration statement with a proxy statement/prospectus if definitive documentation is reached.
• · The Company's extension proxy statement was mailed to shareholders on or about October 16, 2026, seeking approval to extend its deadline to complete an initial business combination.
• · Risk factors flagged include possible termination of negotiations, redemptions by public shareholders, failure to secure PIPE commitments, and the risk of not completing a deal by the business combination deadline.
• · Financial projections and market information for David's Bridal and Pearl were provided solely by David's Bridal and were not independently verified by the Company.

23-10-2026

Foremost Clean Energy Ltd. (FMSTW) filed a Form 6-K for October 2026 furnishing a press release dated October 22, 2026 as Exhibit 99.1, which is incorporated by reference. The filing body itself contains no financial figures, operational metrics, or named initiatives; the substantive content resides entirely in the unattached press release.

• · Filing is a Form 6-K under Rule 13a-16 for a foreign private issuer that files annual reports on Form 20-F, with the company's principal executive office at 750 West Pender Street, Suite 250, Vancouver, BC, V6C 2T7.
• · Commission File Number 001-41769.
• · The referenced press release (Exhibit 99.1) is not included in the provided content, so no financial figures, guidance, or event details can be verified from this filing alone.